Search Clinical Trials
589,279 trials
ID
Status
Phase
Title
Sponsor
NCT07647133
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney DiseaseShenzhen Salubris Pharmaceuticals Co., Ltd.Not Yet RecruitingPhase 2
NCT07647133Not Yet Recruiting
Phase 2
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses i...Shenzhen Salubris Pharmac...
NCT07648160
Contrast-enhanced CBCT With C-arm HyperSight TechnologyUniversity Health Network, TorontoNot Yet RecruitingNot Applicable
NCT07648160Not Yet Recruiting
Not Applicable
Contrast-enhanced CBCT With C-arm HyperSight TechnologyUniversity Health Network...
NCT07647835
3 vs. 5 Days of Amoxicillin for Childhood Pneumonia: An RCTKhyber Teaching HospitalNot Yet RecruitingEarly Phase 1
NCT07647835Not Yet Recruiting
Early Phase 1
3 vs. 5 Days of Amoxicillin for Childhood Pneumonia: An RCTKhyber Teaching Hospital
NCT07646769
Health Belief Model-Based Podcast Education for Premenstrual Symptoms in University StudentsMedipol UniversityCompletedNot Applicable
NCT07646769Completed
Not Applicable
Health Belief Model-Based Podcast Education for Premenstrual Symptoms in Univers...Medipol University
NCT07648901
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain InjuryBaylor Research InstituteNot Yet Recruiting
NCT07648901Not Yet Recruiting
—
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity...Baylor Research Institute
NCT07646951
Aquatic Therapy Versus Sensory Room Intervention for Sensory-Motor Function in Children With Sensory Processing DisorderMTI UniversityNot Yet RecruitingNot Applicable
NCT07646951Not Yet Recruiting
Not Applicable
Aquatic Therapy Versus Sensory Room Intervention for Sensory-Motor Function in C...MTI University
NCT07648264
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesCSL BehringNot Yet RecruitingPhase 3
NCT07648264Not Yet Recruiting
Phase 3
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to...CSL Behring
NCT07648836
Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic ArthritisAssiut UniversityNot Yet Recruiting
NCT07648836Not Yet Recruiting
—
Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psor...Assiut University
NCT07648238
Mentalizing Imagery Therapy for Caregivers to Address Risk of Elder MistreatmentNational Institute on Aging (NIA)Not Yet RecruitingNot Applicable
NCT07648238Not Yet Recruiting
Not Applicable
Mentalizing Imagery Therapy for Caregivers to Address Risk of Elder MistreatmentNational Institute on Agi...
NCT07647861
Efficacy of Lasers, Propolis-Based Agent, and Sham for Dentine HypersensitivityOndokuz Mayıs UniversityCompletedNot Applicable
NCT07647861Completed
Not Applicable
Efficacy of Lasers, Propolis-Based Agent, and Sham for Dentine HypersensitivityOndokuz Mayıs University
NCT07647809
Clinical Pilates and Prenatal Education on Perinatal Depressive SymptomsGaziosmanpasa Research and Education HospitalCompletedNot Applicable
NCT07647809Completed
Not Applicable
Clinical Pilates and Prenatal Education on Perinatal Depressive SymptomsGaziosmanpasa Research an...
NCT07647328
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast CancerAstraZenecaNot Yet RecruitingPhase 3
NCT07647328Not Yet Recruiting
Phase 3
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2...AstraZeneca
NCT07646652
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body DiseaseStanford UniversityNot Yet Recruiting
NCT07646652Not Yet Recruiting
—
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Sym...Stanford University
NCT07647783
A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 TabletsInnovStone Therapeutics LimitedRecruitingPhase 1
NCT07647783Recruiting
Phase 1
A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pha...InnovStone Therapeutics L...
NCT07648381
Corpus Luteum Function and Cardiovascular Adaptation in a Natural MOCK Cycle.Universitair Ziekenhuis BrusselNot Yet Recruiting
NCT07648381Not Yet Recruiting
—
Corpus Luteum Function and Cardiovascular Adaptation in a Natural MOCK Cycle.Universitair Ziekenhuis B...
NCT07648017
Resoloy Initial Safety EvaluationMeKo Manufacturing e.K.Active Not RecruitingNot Applicable
NCT07648017Active Not Recruiting
Not Applicable
Resoloy Initial Safety EvaluationMeKo Manufacturing e.K.
NCT07647432
HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIVPfizerNot Yet RecruitingPhase 2
NCT07647432Not Yet Recruiting
Phase 2
HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed...Pfizer
NCT07647445
Prostate MRI Analysis by Radiologists and Artificial Intelligence - Disease Identification and Guided ManagementLucida Medical LtdNot Yet RecruitingNot Applicable
NCT07647445Not Yet Recruiting
Not Applicable
Prostate MRI Analysis by Radiologists and Artificial Intelligence - Disease Iden...Lucida Medical Ltd
NCT07647224
A Clinical Trial of Multiple Doses of GR2301 Injection in Healthy Adult Trial Participants in China.Genrix (Shanghai) Biopharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07647224Not Yet Recruiting
Phase 1
A Clinical Trial of Multiple Doses of GR2301 Injection in Healthy Adult Trial Pa...Genrix (Shanghai) Biophar...
Result Breakdown
Not yet recruiting14 (70%)
Completed3 (15%)
Recruiting2 (10%)
Active, not recruiting1 (5%)
not_applicable8 (40%)
Not Specified5 (25%)
Phase 22 (10%)
Phase 32 (10%)
Phase 12 (10%)
Early Phase 11 (5%)